Key Takeaways
Bayer AG (BAYGn.DE) reported first-quarter adjusted operating profit rose 9 percent, as its agricultural division outperformed expectations and offset weakness elsewhere.
The German pharmaceutical and agricultural company on Tuesday said quarterly earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at 4.45 billion euros ($5.23 billion). That surpassed the average analyst expectation of 3.93 billion euros, according to a company-published consensus.
The results were driven by a strong performance in the Crop Science division, where adjusted EBITDA jumped 17.9% to 3.0 billion euros. The company said the increase was boosted by the resolution of a soy licensing dispute with its rival Corteva Inc. (CTVA.N).
Bayer confirmed its full-year 2026 guidance on a currency-adjusted basis. The positive earnings report provides a solid start to the year for the company as it navigates ongoing legal challenges and works to restore investor confidence. The strong performance in the agricultural unit underscores the value of its integrated business model. Investors will watch to see if the company can maintain this momentum in the coming quarters.
This article is for informational purposes only and does not constitute investment advice.
